112 related articles for article (PubMed ID: 30769084)
1. Considerations in multi-gene panel testing in pediatric ophthalmology.
Turriff AE; Cukras CA; Brooks BP; Huryn LA
J AAPOS; 2019 Jun; 23(3):163-165.e1. PubMed ID: 30769084
[TBL] [Abstract][Full Text] [Related]
2. An Ophthalmic Rating Scale to Assess Ocular Involvement in Juvenile CLN3 Disease.
Dulz S; Atiskova Y; Wibbeler E; Wildner J; Wagenfeld L; Schwering C; Nickel M; Bartsch U; Spitzer MS; Schulz A
Am J Ophthalmol; 2020 Dec; 220():64-71. PubMed ID: 32707205
[TBL] [Abstract][Full Text] [Related]
3. Detailed Clinical Phenotype and Molecular Genetic Findings in CLN3-Associated Isolated Retinal Degeneration.
Ku CA; Hull S; Arno G; Vincent A; Carss K; Kayton R; Weeks D; Anderson GW; Geraets R; Parker C; Pearce DA; Michaelides M; MacLaren RE; Robson AG; Holder GE; Heon E; Raymond FL; Moore AT; Webster AR; Pennesi ME
JAMA Ophthalmol; 2017 Jul; 135(7):749-760. PubMed ID: 28542676
[TBL] [Abstract][Full Text] [Related]
4. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.
Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT
Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive Treatment for Retinal Degeneration in Juvenile Neuronal Ceroid Lipofuscinosis (Juvenile Batten Disease).
Drack AV; Mullins RF; Pfeifer WL; Augustine EF; Stasheff SF; Hong SD
Ophthalmic Genet; 2015; 36(4):359-64. PubMed ID: 24547931
[TBL] [Abstract][Full Text] [Related]
6. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3).
Chen FK; Zhang X; Eintracht J; Zhang D; Arunachalam S; Thompson JA; Chelva E; Mallon D; Chen SC; McLaren T; Lamey T; De Roach J; McLenachan S
Doc Ophthalmol; 2019 Feb; 138(1):55-70. PubMed ID: 30446867
[TBL] [Abstract][Full Text] [Related]
8. Retinal Phenotype of Patients With Isolated Retinal Degeneration Due to CLN3 Pathogenic Variants in a French Retinitis Pigmentosa Cohort.
Smirnov VM; Nassisi M; Solis Hernandez C; Méjécase C; El Shamieh S; Condroyer C; Antonio A; Meunier I; Andrieu C; Defoort-Dhellemmes S; Mohand-Said S; Sahel JA; Audo I; Zeitz C
JAMA Ophthalmol; 2021 Mar; 139(3):278-291. PubMed ID: 33507216
[TBL] [Abstract][Full Text] [Related]
9. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis].
Taschner PE; Losekoot M; Breuning MH; Hofman I; van Diggelen OP
Ned Tijdschr Geneeskd; 2005 Feb; 149(6):300-3. PubMed ID: 15730038
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation with minocycline rescues retinal degeneration in juvenile neuronal ceroid lipofuscinosis mice highly susceptible to light damage.
Dannhausen K; Möhle C; Langmann T
Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30042155
[TBL] [Abstract][Full Text] [Related]
11. Anaesthesia and orphan disease: a child with neuronal ceroid lipofuscinosis.
Richa F
Eur J Anaesthesiol; 2015 Mar; 32(3):213-5. PubMed ID: 24979587
[No Abstract] [Full Text] [Related]
12. Next-Generation Sequencing in the Diagnosis of Juvenile Neuronal Ceroid Lipofuscinosis.
Deacon BS; Charles JM; Cheeseman EW; Cathey SS
Pediatr Neurol; 2016 Sep; 62():71-2. PubMed ID: 27215405
[No Abstract] [Full Text] [Related]
13. Mutational analysis of the feline CLN3 gene and an ultrastructural evaluation of lysosomal storage materials in a cat with neuronal ceroid lipofuscinosis: an investigation into the molecular basis of the disease.
Furusawa Y; Mizukami K; Yabuki A; Kuwamura M; Chang HS; Hossain MA; Rahman MM; Uddin MM; Mitani S; Yamato O
Vet J; 2012 Dec; 194(3):425-8. PubMed ID: 22627044
[TBL] [Abstract][Full Text] [Related]
14. Ocular morphology and function in juvenile neuronal ceroid lipofuscinosis (CLN3) in the first decade of life.
Preising MN; Abura M; Jäger M; Wassill KH; Lorenz B
Ophthalmic Genet; 2017; 38(3):252-259. PubMed ID: 27486012
[TBL] [Abstract][Full Text] [Related]
15. OPTICAL COHERENCE TOMOGRAPHY IN JUVENILE NEURONAL CEROID LIPOFUSCINOSIS.
Hansen MS; Hove MN; Jensen H; Larsen M
Retin Cases Brief Rep; 2016; 10(2):137-9. PubMed ID: 26308342
[TBL] [Abstract][Full Text] [Related]
16. Further Characterization of the Predominant Inner Retinal Degeneration of Aging Cln3
Volz C; Mirza M; Langmann T; Jägle H
Adv Exp Med Biol; 2018; 1074():403-411. PubMed ID: 29721970
[TBL] [Abstract][Full Text] [Related]
17. Is myopathy with rimmed vacuoles a hallmark of juvenile neuronal ceroid lipofuscinosis (CLN3)?
Borgione E; Castello F; Lo Giudice M; Santa Paola S; Salvatore S; Berti G; Malandrini A; Bottitta M; Musumeci SA; Scuderi C
Neurol Sci; 2016 May; 37(5):805-7. PubMed ID: 26700800
[No Abstract] [Full Text] [Related]
18. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
[TBL] [Abstract][Full Text] [Related]
19. A Case of Unexpected Adult-Onset Neurologic Decline in CLN3-Associated Retinal Degeneration.
Kuper WFE; van Alfen C; van Eck L; van den Broek BTA; Huisman A; van Genderen MM; van Hasselt PM
JAMA Ophthalmol; 2017 Dec; 135(12):1451-1453. PubMed ID: 29049447
[No Abstract] [Full Text] [Related]
20. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
Drack AV; Miller JN; Pearce DA
J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
